Deutsche Bank Maintains Buy on Praxis Precision Medicine, Lowers Price Target to $374

Benzinga Newsdesk www.benzinga.com Negative 71.1%

Neg 71.1% Neu 0% Pos 0%

Deutsche Bank analyst David Hoang maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Buy and lowers the price target from $420 to $374.